v3.26.1
Unaudited Condensed Interim Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:          
Net loss $ (7,392) $ (13,318) $ (10,344) $ (14,044) $ (23,879)
Adjustments to profit and loss items:          
Depreciation and amortization 402 394 780 752 1,860
Share-based compensation 755 862 1,399 1,706 3,108
Revaluation of warrants accounted at fair value (2,811) 6,647 (7,747) 2,377 (2,158)
Revaluation of liabilities in respect of IIA grants 305 203 539 446 380
Financing expenses and exchange differences of lease liability 725 938 960 943 1,725
Increase (decrease) in severance pay liability, net 9 48 (147) 75 31
Other expenses (income) 0 0 0 4 (13)
Financial income, net (391) (424) (925) (942) (1,891)
Un-realized foreign currency gain (107) (6) (91) (21) (51)
Adjustments to profit and loss items, total (1,113) 8,662 (5,232) 5,340 2,991
Changes in asset and liability items:          
Decrease (increase) in trade receivables (478) (1,671) (83) (217) 3,211
Decrease (increase) in inventories 655 (263) (31) (1,151) (1,363)
Decrease (increase) in other receivables (567) 37 (1,300) (341) 1,665
Increase (decrease) in trade payables and accrued expenses 37 794 (151) 691 2,350
Increase in grants received in advance 0 0 724 0 0
Increase (decrease) in other payables (269) 3 536 (144) (1,096)
Changes in asset and liability items, total (622) (1,100) (305) (1,162) 4,767
Net cash used in operating activities (9,127) (5,756) (15,881) (9,866) (16,121)
Cash Flows from Investing Activities:          
Purchase of property and equipment (1,074) (1,049) (2,894) (2,008) (5,505)
Interest received 83 319 659 585 1,591
Proceeds from (investment in) short-term bank deposits, net (1,400) 5,635 17,600 2,985 (14,036)
Net cash provided by (used in) investing activities (2,391) 4,905 15,365 1,562 (17,950)
Cash Flows from Financing Activities:          
Repayment of lease liabilities (365) (289) (702) (537) (1,212)
Proceeds from exercise of warrants and share options 767 838 767 838 3,630
Proceeds from issuance of shares 0 0 0 0 27,416
Repayment of IIA grants 0 0 (84) (114) (214)
Net cash provided by (used in) financing activities 402 549 (19) 187 29,620
Exchange rate differences on cash and cash equivalent balances 109 2 80 21 95
Decrease in cash and cash equivalents (11,007) (300) (455) (8,096) (4,356)
Balance of cash and cash equivalents at the beginning of the period 15,351 1,359 4,799 9,155 9,155
Balance of cash and cash equivalents at the end of the period 4,344 1,059 4,344 1,059 4,799
Supplemental disclosure of non-cash transactions:          
ROU asset, net, recognized with corresponding lease liability 81 1,080 208 1,254 1,433
Purchase of property and equipment in trade payables $ (169) $ (91) $ (395) $ (249) $ (268)